Abstract:BACKGROUND:The development of a safe, effective, and affordable microbicide to prevent the sexual transmission of HIV combination is urgently needed. Our previous studies demonstrated that 3-hydroxyphthalic anhydride-modified chicken ovalbumin (HP-OVA) exhibited potent antiviral activity against a broad spectrum of HIV, simian immunodeficiency virus, and herpes simplex virus, making it a promising candidate as a component of combination microbicide. We intended to evaluate potential the synergistic anti-HIV-1 effect of HP-OVA in combination with antiretroviral drug (ARV)-based microbicide candidates.METHODS:The antiviral activity of HP-OVA and the ARVs, including HIV-1 entry inhibitors (T20, C52L, NB64, NBD556, AMD3100, and Maraviroc) and reverse transcriptase inhibitors (Tenofovir, UC781, and TMC120), tested alone or in combination, against HIV-1 X4 and R5 viruses, including some drug-resistant strains, was determined in MT-2 and peripheral blood mononuclear cells using p24 assay. The immune responses induced by HP-OVA that was applied in the vaginas of rats were detected by enzyme-linked immunosorbent assay.RESULTS:When each of these ARV-based microbicide candidates was combined with HP-OVA, synergistic activity was observed against infection by both X4 and R5 strains, and the degree of synergy differed in each case. HP-OVA was highly effective against several ARV-resistant HIV-1 strains, suggesting that combining HP-OVA with these ARV-based microbicide candidates might work cooperatively against both drug-sensitive and -resistant HIV-1 strains. Human body fluids and human proteins had little or no effects on HP-OVA-mediated inhibitory activity against HIV-1 infection. HP-OVA formulated in the universal gel maintained its antiviral activity for at least 1 month and only induced weak immune responses after its multiple applications in the vaginas of rats.CONCLUSIONS:Synergistic and complementary effects against infection by a broad spectrum of HIV-1 strains were observed by combining HP-OVA with the ARV-based microbicide candidates. These findings provide a sound scientific platform for the development of a safe, effective, and affordable combination microbicide to prevent the sexual transmission of HIV and other sexually transmissible viruses.

3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin Exhibits Potent and Broad Anti-Hiv-1 Activity: a Potential Microbicide for Preventing Sexual Transmission of HIV-1.

3-Hydroxyphthalic anhydride-modified human serum albumin as a microbicide candidate inhibits HIV infection by blocking viral entry.

Combinations of 3-Hydroxyphthalic Anhydride-Modified Ovalbumin with Antiretroviral Drug-Based Microbicide Candidates Display Synergistic and Complementary Effects Against HIV-1 Infection.

Maleic anhydride-modified chicken ovalbumin as an effective and inexpensive anti-HIV microbicide candidate for prevention of HIV sexual transmission

3-Hydroxyphthalic Anhydride-Modified Human Serum Albumin As a Microbicide Candidate Against HIV Type 1 Entry by Targeting Both Viral Envelope Glycoprotein Gp120 and Cellular Receptor CD4

Bovine Beta-Lactoglobulin Modified By 3-Hydroxyphthalic Anhydride Blocks The Cd4 Cell Receptor For Hiv

3-Hydroxyphthaloyl-β-lactoglobulin. I. Optimization of Production and Comparison with Other Compounds Considered for Chemoprophylaxis of Mucosally Transmitted Human Immunodeficiency Virus Type 1

3-Hydroxyphthaloyl-β-lactoglobulin. II. Anti-Human Immunodeficiency Virus Type 1 Activity Inin VitroEnvironments Relevant to Prevention of Sexual Transmission of the Virus

3-Hydroxyphthalic Anhydride- Modified Rabbit Anti-PAP IgG As a Potential Bifunctional HIV-1 Entry Inhibitor

A clinically used anti-human papilloma virus agent (3-hydroxyphthalic anhydride-modified bovine β-lactoglobulin) has a potential for topical application to prevent sexual transmission of monkeypox virus

Chemically Modified Bovine Beta-Lactoglobulin Inhibits Human Papillomavirus Infection

P839 A Chemically Modified Β-Lactoglobulin (JB01) is Effective in Treating HPV Infection and Preventing Sexual Transmission of HIV

Peptidic HIV-1 Fusion Inhibitor VIR576 As a Potential Dual- Functional Microbicide Inhibits Antigen-Specific CD4(+) T-cell Activation.

The Underlying Mechanism of 3-Hydroxyphthalic Anhydride-Modified Bovine Beta-Lactoglobulin to Block Human Papillomavirus Entry into the Host Cell

An engineered HIV-1 gp41 trimeric coiled coil with increased stability and anti-HIV-1 activity: implication for developing anti-HIV microbicides.

Microbicides: a new hope for HIV prevention

Tetrahydrocurcumin-loaded vaginal nanomicrobicide for prophylaxis of HIV/AIDS: in silico study, formulation development, and in vitro evaluation

Progress in the research of topical microbicides against HIV

Vaginal Gel Formulation Based on Theaflavin Derivatives As a Microbicide to Prevent HIV Sexual Transmission.

Inhibition of HIV Virus by Neutralizing Vhh Attached to Dual Functional Liposomes Encapsulating Dapivirine

Efficacy, Stability, and Biosafety of Sifuvirtide Gel As A Microbicide Candidate Against Hiv-1